Unidad de Coloproctología del HUGetafe

Nuestros mejores deseos para este 2026 🎄.

@ColonGetafe @GermFTsurgery @prehab4cancer @me4_so @SoMe4SurgeryPr1 @SocGerMadrid @FISIOSEPAR @coloproctoaec @AECP_FAECP @CirujanosMad @ContraCancerEs prehabilitacionquirurgica.es Aquí tenéis toda la info y el enlace para inscripción. ¡¡¡No lo dejéis que vuelan!!!

🟢Te lo puedes descargar gratis.

🚨 Don’t miss the prestigious @Dukes_Club Lecture #ACPGBI2026 with Prof George Chang on 🩺 “Advanced Rectal Cancer” Chaired by@ioannadrami (Dukes’ Club President) A key session for anyone involved in colorectal surgery & oncology 🎟️ Register now: bit.ly/ACPGBI2026-Reg

@DrCarlosCerdan @GermFTsurgery @prehab4cancer @me4_so @SoMe4SurgeryPr1 @SocGerMadrid @FISIOSEPAR @coloproctoaec @AECP_FAECP @CirujanosMad @ContraCancerEs Donde nos inscribimos?

¿Estás interesado en los cuidados preoperatorios y la Prehabilitación? ¡¡¡Esta jornada es para ti!!! Temas candentes, ponentes de primer nivel y tiempo para discusión y compartir ideas. No te lo pierdas. Ya se han ocupado más de la mitad de las plazas. ¡¡¡Corre, inscríbete ya!!!

Tomorrow. Dr @AnaOtero_MD demonstrates robotic LAR and mesorectal dissection. The session covers systematic landmarks from docking to ICG perfusion assessment. Educational video available May 20. aismedicalnetwork.com/live/robotic-a… #Surgery #MedEd

Join us for a FREE TCOL virtual session! Sign up here --> bit.ly/4nEBp3h On 9 June our EIC Dr Perez and AE Dr McKechnie will host coauthors Dr Meyer and Dr Douissard for the presentation and discussion of their TCOL article "Fascial closure techniques at stoma reversal"

Practice Pearls this month with a clarification of the concepts of total and tailored mesorectal excision for rectal cancer by Drs Moran, Laurberg & Heald. Read more in this month's #DCRJournal: bit.ly/4f1n0Mb

Getting to the bottom of perianal Crohn’s disease 🍑🔎 In @FrontGastro_BMJ, this practical review brings together essential insights into perianal Crohn’s disease — from recognising disease phenotype to multidisciplinary assessment, medical therapy and surgical collaboration. 🧑‍⚕️🤝 A must-read for IBD teams managing one of the most complex and life-altering Crohn’s phenotypes. Read more: fg.bmj.com/content/early/… #PerianalCrohns #CrohnsDisease #IBD #Fistula #IBDSurgery #FrontlineGastro #GItwitter #InflammatoryBowelDisease #IBDTreatment #ColorectalSurgery @eathar_s @easan_anand @TheoHPelly @Shivani_gargi15 @philtozer1 @DrAilsaHart @BritSocGastro @my_UEG @AmCollegeGastro @DDWMeeting @ESGE_news @dr_aditi_kumar @OTavabie @DrJMKennedy @DunnePdj @TrevorTabone @IrenePerezMD @KGananandan @zare_benjamin @medicalreg @dtleiberman

Joint ESTRO - ESR talk on rectal cancer. My take-away: Anatomy remains core for treatment selection. However focus should also be on predicted biology, response, preservation of function and quality of life. @GI_RadOnc @OncoAlert #ESTRO26 @estro

Locally advanced rectal cancer: what patients and practitioners should know about non-operative management - eClinicalMedicine thelancet.com/journals/eclin…

This month's Resident Corner focuses on Shared Decision-Making in Locally Advanced Rectal Cancer. Read now in #DCRJournal: bit.ly/3QNTTSA

Response to the Letter to the Editor "Organ Preservation in Locally Advanced Rectal Cancer After Total Neoadjuvant Therapy With Endoscopic Submucosal Dissection" Read the authors' response now in #DCRJournal: bit.ly/3QXDPhb

This is a great read on watch & wait in rectal cancer. B/c patients with local regrowth after WW have higher rates of distant mets, there has been an intuitive fear that regrowth is causal (i.e delaying TME permits metastatic seeding hence WW risky). The authors here argue (and I agree) that regrowth/metastases are manifestations of intrinsic aggressive tumor biology because: 1) no difference in time to surgery in patients w pCR/regrowth who developed mets vs. those who didn't (if delay were causal, would expect longer delay in patients who developed M1). 2) in OPRA secondary analysis, patients with cCR underwent least surgery/longest observation while those with incomplete response had surgery most frequently/immediately. But outcomes still tracked with response phenotype not timing of surgery (i.e. cCR did best). 3) tumor response itself is prognostic (i.e. even when all pts undergo TME, more regression after neoadjuvant therapy --> better DFS/DM). 4) modern tumor evolution data suggest metastatic spread mostly happens early. 5) chemo/radioresistance appears to be linked to metastatic potential (i.e. regrowth is a marker of aggressive biology not the mechanism itself). IMO a persuasive argument against hypothesis that regrowth seeds metastasis, but rather biology=dominant driver. @OncoAlert

Our meta-Analysis on the association between colorectal anastomotic leak and LARS @ColorectalDis @SWexner @BoutrosMarylise @nirhoresh @AWignakumar @ZGaroufalia @LARSCollab8950 pubmed.ncbi.nlm.nih.gov/40808658/

Watch and Wait for Rectal Cancer: A Risky Gamble or a Safe Strategy for Patients With a Near-Complete Response? | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

📊 JAMA Clinical Guidelines Synopsis: #CrohnDisease guidelines recommend fecal calprotectin for screening and monitoring, routine colonoscopy for colorectal cancer, and oral budesonide for induction in mild to moderate ileocecal disease. ja.ma/49k6fbp

New article in press: Colorectal cancer detection using non-contrast CT and deep learning: a multicenter and international cohort study doi.org/10.1016/j.anno…

#DCRJournal didactic video Recap | on Delorme Procedure - watch it today on our YouTube channel: bit.ly/3H8nZrT @jendavidsmd @ScottRSteeleMD @Swexner @me4_so @ACPGBI @drtracyhull @ASCRS_1 @FicheraAlessand

Watch "Single-Port Robotic Right Colectomy: A Technical Video Report" only in #DCRJournal: bit.ly/47AotEV @PatriciaMrcln; @bidmccrs

Missed our latest ESCP Global Reach webinar? Watch the recording on Low Anterior Resection Syndrome (LARS) 🌍—exploring global research, patient impact & management strategies. 🎥 escp.eu.com/global-reach/w… #ColorectalSurgery #LARS #GlobalSurgery